Announcements Trials

Browse Landscape

Phase

Phase 2 20 Phase 1/2 9 Phase NA 7 Phase 1 7 Phase 4 4 Phase 3 3 Phase EARLY_PHASE1 2 Phase 2/3 1

Status

Recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 9 Recurrence 6 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Squamous Cell 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Melanoma 4 Liver Neoplasms 4 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Hematologic Neoplasms 3 Fatigue 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Depression 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2

Interventions

pembrolizumab 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Terminated × Skin Neoplasms × Clear all

NCT06295809 2026-05-08

INTerpath-007

Merck Sharp & Dohme LLC

Phase 2/3 Terminated

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡